Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$50.62+2.40 (+4.98%)
Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –
Prestige Consumer Healthcare total assets
Total assets on the balance sheet at the end of each period.
Prestige Consumer Healthcare's total assets was $4.57B at Jun 30, 2026. For fiscal 2026 it was $3.49B, up 2.7% from the year before. Over ten years it grew 1.7% a year on average. The highest annual figure on record is $3.91B in fiscal 2017.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $3.49B | +2.7% |
| FY2025 | Mar 31, 2025 | $3.40B | +2.5% |
| FY2024 | Mar 31, 2024 | $3.32B | -1.1% |
| FY2023 | Mar 31, 2023 | $3.35B | -8.6% |
| FY2022 | Mar 31, 2022 | $3.67B | +7.0% |
| FY2021 | Mar 31, 2021 | $3.43B | -2.4% |
| FY2020 | Mar 31, 2020 | $3.51B | +2.1% |
| FY2019 | Mar 31, 2019 | $3.44B | -8.5% |
| FY2018 | Mar 31, 2018 | $3.76B | -3.9% |
| FY2017 | Mar 31, 2017 | $3.91B | +32.6% |
| FY2016 | Mar 31, 2016 | $2.95B | +11.6% |
| FY2015 | Mar 31, 2015 | $2.64B | +47.1% |
| FY2014 | Mar 31, 2014 | $1.80B | +3.2% |
| FY2013 | Mar 31, 2013 | $1.74B | -1.1% |
| FY2012 | Mar 31, 2012 | $1.76B | +66.4% |
| FY2011 | Mar 31, 2011 | $1.06B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $4.57B | +33.1% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $3.49B | +2.7% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $3.49B | +5.0% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $3.44B | +3.8% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $3.43B | +3.8% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $3.40B | +2.5% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $3.33B | -0.3% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $3.32B | -0.5% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $3.31B | -1.1% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $3.32B | -1.1% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $3.34B | -10.9% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $3.33B | -9.4% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $3.35B | -9.1% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $3.35B | -8.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $3.75B | +2.5% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $3.68B | +0.1% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $3.68B | +3.5% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $3.67B | +7.0% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $3.66B | +5.5% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $3.68B | +7.0% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $3.56B | +3.2% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $3.43B | -2.4% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $3.47B | +0.1% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $3.43B | -0.9% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $3.45B | -0.3% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $3.51B | +2.1% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $3.46B | -5.6% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $3.46B | -6.3% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $3.46B | -8.2% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $3.44B | -8.5% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $3.67B | -5.9% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $3.70B | -5.2% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $3.77B | -3.4% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $3.76B | -3.9% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $3.90B | +38.7% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $3.90B | +37.8% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $3.90B | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $3.91B | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $2.81B | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $2.83B | – |
See a number that looks wrong?